PATRICIA ESMERALDA
CARREIRA DELGADO
Profesora asociada de Ciencias de la Salud
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (184)
2024
-
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97
2023
-
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
JAMA dermatology, Vol. 159, Núm. 8, pp. 837-847
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553
-
Gender biases in Spanish rheumatology: Perception and facts
Reumatologia Clinica, Vol. 19, Núm. 7, pp. 392-401
-
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
Rheumatology (Oxford, England), Vol. 62, Núm. 4, pp. 1559-1567
-
Immunoglobulins in systemic sclerosis management. A large multicenter experience
Autoimmunity Reviews, Vol. 22, Núm. 11
-
The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis–Associated Interstitial Lung Disease
Journal of Clinical Medicine, Vol. 12, Núm. 20
2022
-
Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison with Adult Patients Analysis from a Multicentric Cohort in Spain
Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E195-E202
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
Annals of the rheumatic diseases, Vol. 81, Núm. 4, pp. 507-515
-
Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis
Immunity and Ageing, Vol. 19, Núm. 1
-
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review
Seminars in Arthritis and Rheumatism, Vol. 52
-
Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis
Journal of immunology (Baltimore, Md. : 1950), Vol. 209, Núm. 1, pp. 38-48
-
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
Reumatologia Clinica, Vol. 18, Núm. 6, pp. 317-330
-
Treatment of Raynaud Phenomenon and Ischemic Ulcers Associated to Systemic Sclerosis with Hyperbaric Oxygen
Reumatologia Clinica, Vol. 18, Núm. 4, pp. 246-248
2021
-
Antifibrotics in systemic sclerosis
Best Practice and Research: Clinical Rheumatology, Vol. 35, Núm. 3
-
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database
Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 213-222
-
Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study
Journal of Psychosomatic Research, Vol. 140
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
-
SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients
Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957